52North is a medical technology company on a mission to make urgent care pathways safer and more effective. Awarded breakthrough status for its first product NeutroCheck® by the UK government in 2024, 52North builds in vitro diagnostic and digital solutions to transform patient journeys in urgent care. Its award-winning, multidisciplinary team is based in Cambridge, UK. 52North is backed by leading UK and US hospital venture funds, Meridian Health Ventures and Cedars-Sinai Intellectual Property Company, and other partners, including the University of Cambridge and Macmillan Cancer Support.

Cambridge, UK

Streetly End, Cambridge CB21 4RP, UK

52 North Health

The Cedars-Sinai Accelerator helps today's technology innovators turn their ideas into breakthroughs. #CSAccelerator

Cedars-Sinai Accelerator

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining Cedars-Sinai Accelerator Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Cedars-Sinai Accelerator network as they come up.

You can always update this information later.

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Cedars-Sinai Accelerator company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Work for companies that improve the lives of healthcare professionals and patients